|
Synonyms: example 56-1 [WO2024201240]
Compound class:
Synthetic organic
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| AZD3632 has been progressed as a clinical anti-tumour agent that is proposed for advanced haematologic malignancies with MLL rearrangements |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT07155226 | Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression | Phase 1/Phase 2 Interventional | AstraZeneca | ||